Scholars Central

Conference abstractPublished 6 Mar 2019

Pharmaceutical: Clinical development strategy and technology

Authors: Francois-Xavier Frapaise

F.-X. Frapaise Consulting, France

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Most patients still have limited or no access to life-changing therapeutic proteins in the treatment of their cancer or autoimmune disorders; the current clinical development model of biosimilars is expensive and in most cases large phase 3 trials do not provide meaningful information on the clinical equivalence between biosimilars and reference compounds. At the same time, the development of orthogonal, state of the art analytical methods has enabled a better understanding of the structure and structurefunction relationship of biotherapeutics. Hence, we suggest here that a solid CMC package, together with meaningful phase 1 studies will leave limited uncertainty on biosimilarity, that – if needed- can be addressed by post-approval long-term follow-up studies (post-approval studies, pharmacovigilance, Real World Evidence data and registries) ; we believe that this new approach may be more appropriate than 600-1000 patients phase 3 trials in assessing biosimilarity and therapeutic equivalence, under the condition that administered biosimilar given to individual patients can clearly be identified. Obviously, it will probably never be a “one size fits all” development model and an individualized, risk-based approach to biosimilar developments will always have to be considered and discussed early with Regulators.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Francois-Xavier Frapaise”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels